On Tuesday, President Donald Trump signed an executive order titled “Protecting Children from Chemical and Surgical Mutilation,” declaring that it is “the policy of the United States that it will not fund, sponsor, promote, assist, or support the so-called ‘transition’ of a child from one sex to another, and it will rigorously enforce all laws that prohibit or limit these destructive and life-altering procedures.”
The executive order directs agencies to rescind or amend policies that rely on guidance from the World Professional Association for Transgender Health (WPATH), including the group’s “Standards of Care Version 8.” The order stated that WPATH’s guidance “lacks scientific integrity.”
The Secretary of Health and Human Services will publish a review within 90 days of the order being signed on the existing literature “on best practices for promoting the health of children who assert gender dysphoria, rapid-onset gender dysphoria, or other identity-based confusion,” and will use “all available methods” to increase the quality of data to guide practices for improving the health of minors with these conditions or “otherwise seek chemical or surgical mutilation.”
The order also directs the heads of executive departments or agencies that provide research or education grants to medical schools to take immediate appropriate steps “to ensure that institutions receiving Federal research or education grants end the chemical and surgical mutilation of children.”
The Secretary of HHS is also ordered to “take all appropriate actions to end the chemical and surgical mutilation of children, including regulatory and sub-regulatory actions” and is ordered to withdraw the Biden HHS’s March 2022 guidance titled “HHS Notice and Guidance on Gender Affirming Care, Civil Rights and Patient Privacy” and issue new guidance protecting whistleblowers “who take action related to ensuring compliance with this order.” […]
— Read More: thepostmillennial.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
